Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes
https://n.neurology.org/content/early/2 ... 1.abstract
Discussion: Ibudilast treatment decreased GCIPL atrophy in PMS, driven by the PPMS cohort, with no effect seen in SPMS. Modulated atrophy of retinal layers may be detectable in sample sizes smaller than the SPRINT-MS trial and correlate with whole brain atrophy in PMS, further highlighting their utility as outcomes in PMS.
Classification of evidence: This study provides Class II evidence that ibudilast reduces composite ganglion cell and inner plexiform layer atrophy, without reduction of inner or outer nuclear layer atrophy, in patients with progressive MS but not those with secondary progressive MS.
Ibudilast works for PPMS but not for SPMS
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1983 Views
-
Last post by NHE
-
- 1 Replies
- 1556 Views
-
Last post by ElliotB
-
- 0 Replies
- 885 Views
-
Last post by frodo
-
- 0 Replies
- 1130 Views
-
Last post by frodo
-
- 0 Replies
- 4399 Views
-
Last post by NHE
-
- 1 Replies
- 1357 Views
-
Last post by vesta
-
- 0 Replies
- 1514 Views
-
Last post by NHE
-
- 4 Replies
- 2493 Views
-
Last post by JohnC777
-
- 0 Replies
- 1580 Views
-
Last post by NHE